B. Ceglarek
Impact in
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research
-
- Lymphoma Diagnosis and Treatment
Papers in
- Genetics 10
- Chronic Lymphocytic Leukemia Research 10
-
- Lymphoma Diagnosis and Treatment 8
- Co-authors
- Tadeusz Robak (8 shared papers)L Konopka (7 shared papers)Anna Dmoszyńska (5 shared papers)Jerzy Z. Błoński (4 shared papers)Andrzej Hellmann (3 shared papers)Jadwiga Dwilewicz‐Trojaczek (4 shared papers)Marek Kasznicki (4 shared papers)S Potoczek (2 shared papers)
- Journals
- Blood (7 papers)Journal of Clinical Oncology (1 paper)European Journal of Cancer (1 paper)Leukemia (1 paper)Cancer (1 paper)
- Partner nations
- PolandUnited StatesThailand
In The Last Decade
B. Ceglarek
13 papers receiving 398 citations
Peers
Comparison fields: 5 of 32
- Genetics 353
- Pathology and Forensic Medicine 251
- Hematology 88
- Immunology 116
- Oncology 60
Countries citing papers authored by B. Ceglarek
This map shows the geographic impact of B. Ceglarek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Ceglarek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Ceglarek more than expected).
Fields of papers citing papers by B. Ceglarek
This network shows the impact of papers produced by B. Ceglarek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Ceglarek. The network helps show where B. Ceglarek may publish in the future.
Co-authors
The 25 scholars most cited alongside B. Ceglarek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 185 | |
| 2 | 2010 | 71 | |
| 3 | 2003 | 55 | |
| 4 | 2001 | 32 | |
| 5 | 2008 | 18 | |
| 6 | 2009 | 12 | |
| 7 | 2009 | 10 | |
| 8 | 2009 | 9 | |
| 9 | 2004 | 8 | |
| 10 | 2020 | 3 | |
| 11 | [Chronic eosinophilic leukemia]. | 2001 | 3 |
| 12 | 2006 | 2 | |
| 13 | 2004 | 2 | |
| 14 | 2015 | 0 |
About B. Ceglarek
B. Ceglarek is a scholar working on Genetics, Pathology and Forensic Medicine, Public Health, Environmental and Occupational Health, Hematology and Rheumatology, having authored 14 papers that have together received 410 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (10 papers), Lymphoma Diagnosis and Treatment (8 papers), Acute Lymphoblastic Leukemia research (5 papers), Chronic Myeloid Leukemia Treatments (3 papers), Immunodeficiency and Autoimmune Disorders (2 papers), Eosinophilic Disorders and Syndromes (2 papers), Cardiovascular Syncope and Autonomic Disorders (1 paper) and Viral Infections and Immunology Research (1 paper). The work is most often cited by research in Genetics (353 citations), Pathology and Forensic Medicine (251 citations), Hematology (88 citations), Immunology (116 citations) and Oncology (60 citations). B. Ceglarek has collaborated with scholars based in Poland, United States and Thailand. Frequent co-authors include Tadeusz Robak, L Konopka, Anna Dmoszyńska, Jerzy Z. Błoński, Andrzej Hellmann, Jadwiga Dwilewicz‐Trojaczek, Marek Kasznicki, S Potoczek, W. Nowak and Aleksander B. Skotnicki. Their work appears in journals such as Blood, Journal of Clinical Oncology, European Journal of Cancer, Leukemia and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.